IP Library Granted Patent US 9,763,453
Granted Patent B2
US 9,763,453 · App. 14/268,473 · Granted Sep 19, 2017

Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation

Inventors: Guy S. Cook (Bozeman, MT); Matt R. Trebella (Bozeman, MT)
Assignee: Bacterin International, Inc.
A01N59/16A01N25/10A61L27/34A61L27/54A61L29/085A61L29/16A61L31/10A61L31/16B05D3/104B05D3/142C09D5/14A61L2300/104A61L2300/406A61L2300/606
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,763,453
App. No.
14/268,473
Granted
Sep 19, 2017
Kind
B2
Abstract

The present invention provides antimicrobial coatings for coating substrate surfaces, particularly medical devices, for preventing bacterial adhesion and biofilm formation by inhibiting microbial growth and proliferation on the coating surface. The antimicrobial coatings are composed of a hydrogel and a bioactive agent including a substantially water-insoluble antimicrobial metallic material that is solubilized within the coating. Antimicrobial coating formulations for obtaining such coatings, and coating methods are also described.

Claims (23)

1. A method of coating a substrate with an antimicrobial coating, the method comprising:

pre-treating a surface of the substrate with a primer layer or a surface oxidant;

preparing a solution comprising nitric acid and silver sulfadiazine;

heating the solution to a temperature between about 65° C. and about 70° C.;

adding polyvinyl alcohol to the solution to form a coating solution;

heating the coating solution to a temperature between about 75° C. and about 80° C. to solubilize the silver sulfadiazine in the coating solution;

depositing a layer of the coating solution containing solubilized silver sulfadiazine on the surface of the substrate;

crosslinking the polyvinyl alcohol within the layer to form a surface immobilized, three-dimensional hydrogel network on the substrate; and

at least partially drying the layer, wherein after at least partially drying the layer, the silver sulfadiazine remains solubilized in the layer.

2. The method of claim 1 , wherein the solution is stirred at 500 rpm for at least 15 minutes while at a temperature between about 65° C. and about 70° C., and wherein the coating solution is stirred for about 3 hours at a temperature between about 75° C. and about 80° C. to solubilize the silver sulfadiazine in the coating solution.

3. The method of claim 1 wherein pre-treating the surface of the substrate material comprises coating the surface of the substrate material with the primer layer on which the antimicrobial coating is deposited.

4. The method of claim 1 wherein pre-treating the surface of the substrate material with a surface oxidant comprises subjecting the substrate material to an oxidation process that is followed by a chemical grafting reaction rendering the surface hydrophilic, and compatible with the coating.

5. The method of claim 1 wherein the surface oxidant comprises plasma.

6. The method of claim 1 wherein the coating composition further comprises a stabilizing agent.

7. The method of claim 6 wherein the stabilizing agent is an antioxidant selected from the group consisting of lactone, phenolic, phosphite, thioester, hindered amine, hindered benozoate or hindered phenolic, and combinations thereof.

8. The method of claim 6 wherein the stabilizing agent is an antioxidant selected from the group consisting of:

1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione; poly-hexamethylene; 3,5-di-t-butyl-4-hydroxybenzoic acid hexadecyl ester; alpha-tocopherol; alpha-tocopherol polyetheylene glycol succinate; alpha-lipoic acid; butylated hydroxy toluene, sodium ascorbate, and combinations thereof.

9. The method of claim 6 wherein the stabilizing agent is a photostabilizer selected from the group consisting of benzoate, benzophenone, benzotriazole, cyanoacrylate, organo nickel or organo zinc.

10. The method of claim 6 wherein the stabilizing agent is selected from the group consisting of TiO 2 , WO 3 , magnesium silicate and mixtures thereof.

11. The method of claim 10 wherein the stabilizing agent comprises TiO 2 .

12. The method of claim 1 further comprising:

chemically grafting an aliphatic alcohol onto the substrate material.

13. The method of claim 1 wherein the silver sulfadiazine is solubilized in the coating solution at a concentration between 1 mg/L and 100 g/L.

Assignments (7)
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068539/0492 →
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 068539/0665 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2021
From: SILICON VALLEY BANK
To: XTANT MEDICAL, INC.; XTANT MEDICAL HOLDINGS, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
Reel/Frame 056493/0457 →
SECURITY INTEREST (TERM) Recorded May 21, 2021
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 056323/0586 →
SECURITY INTEREST (REVOLVING) Recorded May 21, 2021
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 056323/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2017
From: COOK, GUY; TREBELLA, MATT
To: BACTERIN
Reel/Frame 042047/0974 →
SECURITY AGREEMENT Recorded Jun 6, 2016
From: XTANT MEDICAL HOLDINGS, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; XTANT MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 038884/0063 →
Continuity (3)
Division 10891885 · Jul 15, 2004
Provisional Application 60566576 · Apr 29, 2004
Related Publication 20150010715A1 · Jan 8, 2015